Li/CFx Battery Technology Developed With End-of-Life Capability
EaglePicher (Booth 957) is showcasing its newly developed Li/CFx technology with End-of-Life Capability. This technology accurately predicts battery depletion six months in advance, meaning fewer surgeries and added confidence in EaglePicher-powered medical devices.
The enhanced Li/CFx battery chemistry provides higher energy density for use in a variety of implantable applications including telemetry-capable pacemakers and ICDs, neurostimulation devices, drug pumps, body fluid pumps, and monitors.
Benefits include proprietary EOL indicator for safe and predictable replacement prior to end of battery life; superior energy density enabling longer life or potentially smaller devices; excellent rate capability for rapid capacitor charging throughout most of the battery life; telemetry capability; elimination of the initial voltage delay commonly seen in Li/CFx batteries; and low self-discharge.